Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus
Authors:
- A. SauerbreiASA. Sauerbrei
- M. SchackeMSM. Schacke
- B. GlückBGB. Glück
- R. EgererRER. Egerer
- P. WutzlerPWP. Wutzler
- 31 December 2006
- journal article
- research article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 64 (4) , 358-365
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Leitlinie der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e.V. und des Robert Koch-Instituts zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin Fassung vom 15. Juni 2005Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2005
- Alternative methods for validation of cell culture infection with duck hepatitis B virusJournal of Virological Methods, 2005
- Molecular approaches to validate disinfectants against human hepatitis B virusMedical Microbiology and Immunology, 2002
- Preventing the spread of hepatitis B and C viruses: Where are germicides relevant?American Journal of Infection Control, 2001
- Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B modelJournal of Vascular Surgery, 1999
- Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated virusesTransfusion, 1997
- Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivityEpidemiology and Infection, 1991
- Experimental transmission of duck hepatitis B virus to pekin ducks and to domestic geeseHepatology, 1987
- Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cellsCell, 1986
- Chemical inactivation of hepatitis B virus: The effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivityJournal of Virological Methods, 1983